James McCracken, MD
University of California, Los Angeles
8
8
8
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (8)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Lawrence Ginsberg, MD
Red Oaks Psychiatry Associates, PA
Shared therapeutic areas:
Worked with same sponsors:
Jeremy Veenstra-VanderWeele, MD
Vanderbilt Kennedy Center
Shared therapeutic areas:
Worked with same sponsors:
Linmarie Sikich, MD
University of North Carolina Neurosciences Hospital
Shared therapeutic areas:
Worked with same sponsors:
Bryan King, MD, PhD
Seattle Children's Hospital
Shared therapeutic areas:
Worked with same sponsors:
Raun Melmed, MD
Southwest Autism Research & Resource Center
Shared therapeutic areas:
Worked with same sponsors:
Craig Erikson, MD
Riley Hospital for Children
Shared therapeutic areas:
Worked with same sponsors:
Lawrence Scahill, PhD
Yale University
Shared therapeutic areas:
Worked with same sponsors:
Lawrence Scahill, MSN, PhD
Emory University
Shared therapeutic areas:
Worked with same sponsors:
Bryan King, MD
Seattle Children's Hospital
Shared therapeutic areas:
Worked with same sponsors:
Robert B Innis, M.D.
National Institute of Mental Health (NIMH)
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (8)
Showing 8 of 8 trials
Risperidone Treatment In Children With Autism Spectrum Disorder And High Levels Of Repetitive Behavior
Safety, Tolerability and Efficacy Study of STX209 in Subjects With Fragile X Syndrome
Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001
Open-Label Study of the Safety and Tolerability of STX209 in Subjects With Autism Spectrum Disorders
Biomarker and DNA Collection in Subjects Participating in Protocol 22003
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism Trial
Combination Treatment for Augmenting Language in Children With ASD
All 8 trials loaded